Showing results (351-360 of 439) with videos related to
Sort By:
Pageof 44
BJU International|August 8, 2009
p53 expression in patients with advanced urothelial cancer of the urinary bladderShahrokh F Shariat, Christian Bolenz, Pierre I Karakiewicz, et al.Nature Reviews. Urology|March 28, 2023
Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic diseaseKyle M Rose, Heather L Huelster, Joshua J Meeks, et al.European Urology Oncology|March 24, 2020
Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysisAshish M Kamat, Seth P Lerner, Michael O'Donnell, et al.Neurosurgical Review|May 18, 2025
Efficacy and safety of intraventricular nimodipine in patients with aneurysmal subarachnoid hemorrhage compared to oral nimodipine: a systematic review and meta-analysisHesham Kelani, Nancy Ibrahim, Ahmed Naeem, et al.European Urology|August 18, 2023
Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605Peter C Black, Catherine M Tangen, Parminder Singh, et al.Journal of the National Cancer Institute|January 15, 2009
Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancerVitaly Margulis, Yair Lotan, Pierre I Karakiewicz, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not MatterAshish M Kamat, Niyati Lobo, Seth P Lerner, et al.Clinical Chemistry|March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancersCatharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.European Urology|May 17, 2023
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk FactorsIbrahim Jubber, Sean Ong, Laura Bukavina, et al.Cancer|March 5, 2013
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working GroupMatthew D Galsky, Ryan Hendricks, Robert Svatek, et al.Pageof 44